Holmes Biopharma, Inc. (LMB) Misses Q2 EPS by 3c, Miss on Revenues; Offers FY17 Revenue Mid-Point Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/9/2026

1. SPY
2. USO
3. META
4. MSFT
5. COST
6. MU
7. IONS
8. ORCL
9. RMR
10. LEVI

Go back to Holmes Biopharma, Inc. (LMB) Misses Q2 EPS by 3c, Miss on Revenues; Offers FY17 Revenue Mid-Point Below Consensus
Holmes Biopharma, Inc. (NASDAQ: LMB) Delayed: 77.58 +0.42 (0.54%)
Previous Close $77.16    52 Week High $0.15 
Open $78.32    52 Week Low $0.15 
Day High $79.46    P/E N/A 
Day Low $77.46    EPS $0.00 
Volume 191,069